Full Text (PDF)
Review Article

Breast Cancer and Its Conventional Treatment: A Preliminary Review

Simrat Kaur, Azeem Bashir, Saloni Verma, S P Subashini

Author Information

Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Indian Journal of Genetics and Molecular Research 11(1):p 21-25, January-June 2022. | DOI: https://doi.org/10.21088/ijgmr.2319.4782.11122.2

How Cite This Article:

Azeem Bashir, Saloni Verma, Simrat Kaur, et. al./Breast Cancer and its Conventional Treatment: A Preliminary Review/Indian J Genet Mol Res. 2022; 11(1):21–25.

Timeline

Received : February 02, 2022         Accepted : March 03, 2022          Published : June 20, 2022

Abstract

Worldwide, breast cancer is the maximum common cancer in ladies and might be the leading cause of most cancers in women. Better-paid nations (HICs) have made terrific strides in enhancing the consequences of breast cancer. Between 1990 and 2014, the mortality price of breast cancers dropped by means of 34 percent due to the combination of superior pre-diagnosis and powerful adjuvant remedies. In evaluation, breast cancer is developing trouble in low- and center-earnings nations (LMICs), where the low prevalence price has risen to 5% according to year. The measures identified within the HICs had been no longer established in LMICs wherein complete control techniques from wealthy countries couldn't be fully utilized because of critical resource constraints associated with constrained personal sources, underdeveloped fitness care infrastructure, drug shortages and cultural obstacles.


References

  • 1.   Abstract: 2016 San Antonio Breast Cancer Symposium; December 6-10, 2016; San Antonio, Texas
  • 2.   https://cancerres.aacrjournals.org/content/77/4_Supplement/IS-1
  • 3.   https://www.cancer.net/cancer-types/breastcancer/introduction
  • 4.   h t t p s : / / w w w . n c b i . n l m . n i h . g o v / b o o k s /NBK179047/

Data Sharing Statement

There are no additional data available. All raw data and code are available upon request.

Funding

This research received no funding.

Author Contributions

All authors contributed significantly to the work and approve its publication.

Ethics Declaration

This article does not involve any human or animal subjects, and therefore does not require ethics approval.

Acknowledgements

We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.

Conflicts of Interest

No conflicts of interest in this work.


About this article


Cite this article

Azeem Bashir, Saloni Verma, Simrat Kaur, et. al./Breast Cancer and its Conventional Treatment: A Preliminary Review/Indian J Genet Mol Res. 2022; 11(1):21–25.


Licence:

Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Received Accepted Published
February 02, 2022 March 03, 2022 June 20, 2022

DOI: https://doi.org/10.21088/ijgmr.2319.4782.11122.2

Keywords

Breast cancer; Cause of most cancers in women; Stage IV bone cancer.

Article Level Metrics

Last Updated

Monday 22 June 2026, 06:10:54 (IST)


942

Accesses

5
274
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received February 02, 2022
Accepted March 03, 2022
Published June 20, 2022

licence


Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)

This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.


Access this article



Share